Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)

0
13
Beef E. coli Outbreak investigation



Legacy Pharmaceutical Packaging, LLC is increasing its consumer-level recall of three repackaged tons Losartan Tablets USP 50mg to incorporate one further lot.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here